No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
Filings
Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.
| Company | Type | Value | Reported | Company | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| MoonLake ImmunotherapeuticsChief Scientific Officer | Open-market sell | $22,0001,100 shares | Jul 29, 2026 | MoonLake ImmunotherapeuticsChief Scientific Officer | $22,000 | Open-market sell | 1,100 | Jul 29, 2026 |
| MoonLake ImmunotherapeuticsChief Scientific Officer | Open-market sell | $48,9602,448 shares | Jul 23, 2026 | MoonLake ImmunotherapeuticsChief Scientific Officer | $48,960 | Open-market sell | 2,448 | Jul 23, 2026 |
| MoonLake ImmunotherapeuticsChief Scientific Officer | Open-market sell | $1,001,00050,000 shares | Jul 23, 2026 | MoonLake ImmunotherapeuticsChief Scientific Officer | $1,001,000 | Open-market sell | 50,000 | Jul 23, 2026 |
| MoonLake ImmunotherapeuticsChief Scientific Officer | Open-market sell | $877,93343,700 shares | Jul 21, 2026 | MoonLake ImmunotherapeuticsChief Scientific Officer | $877,933 | Open-market sell | 43,700 | Jul 21, 2026 |
| MoonLake ImmunotherapeuticsChief Scientific Officer | Open-market sell | $322,26116,105 shares | Jul 20, 2026 | MoonLake ImmunotherapeuticsChief Scientific Officer | $322,261 | Open-market sell | 16,105 | Jul 20, 2026 |